drugset / Trial / NCT04372394

A Study to Assess the Effect of a High Fat Meal on Surufatinib in Healthy Subjects

NCT04372394

Phase 1 Completed 28 enrolled Hutchison Medipharma Limited
RandomizedParallel-groupOpen-labelBasic science

Summary

This study will be a 2-period study conducted with 26 healthy male or female subjects. Subjects will be randomly assigned to either receive a single dose of surufatinib with food in period 1, then without food in period 2, or vice-versa.

Timeline

Start
2020-08-14
Primary completion
2020-10-31
Completion
2021-03-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Surufatinib Small molecule 300 mg

Indications

No indication recorded.